Category: Zacks Small Cap Research
By John Vandermosten, CFANASDAQ:NOVN READ THE LATEST NOVN RESEARCH REPORT Novan, Inc. (NASDAQ:NOVN) announced on January 19, 2021 that it had achieved 90% enrollment for its pivotal B-SIMPLE4 trial indicating 765 patients have been added. The trial i ...
By John Vandermosten, CFANASDAQ:TENX Tenax Acquires PH Precision Med Tenax Therapeutics, Inc. (NASDAQ:TENX) announced yesterday the acquisition of privately held, clinical stage PH Precision Med (PHPM) in an equity deal valued at approximately $21.6 ...
By John Vandermosten, CFANASDAQ:LPCN Positive Topline Phase II Results from Ongoing LiFT Study, Update Includes Comparison Lipocine Inc. (NASDAQ:LPCN) announced positive topline data from LiFT (1), a Phase II study of its candidate LPCN 1144 in biop ...
By Steven Ralston, CFAOTC:ALVOF | TSX:ALV READ THE FULL ALVOF RESEARCH REPORT Operating in Brazil, Alvopetro Energy (OTC:ALVOF) (TSX:ALV) is an upstream producer of natural gas with midstream assets. After several years of development, the company be ...
By John VandermostenNASDAQ:RVPH READ THE PREVIOUS RVPH RESEARCH REPORT Initiating Coverage We are initiating coverage of Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) with a current valuation of $21.00 per share. This present value is based on o ...
By David Bautz, PhDOTC:MATN READ THE FULL MATN RESEARCH REPORT Business Update Positive Interim Data for ARTIVeda™ in COVID-19 Trial On January 13, 2021, Mateon Therapeutics, Inc. (OTC:MATN) announced positive interim data for ARTIVeda™/ArtiShield™ ...
By John VandermostenNASDAQ:LPCN READ THE PREVIOUS LPCN RESEARCH REPORT Positive Topline Phase II Results from Ongoing LiFT Study Lipocine Inc. (NASDAQ:LPCN) announced positive topline data from LiFT (1), a Phase II study of its candidate LPCN 1144 i ...
By David Bautz, PhDNASDAQ:VKTX READ THE FULL VKTX RESEARCH REPORT Business Update Management Provides Update on 2021 Outlook We recently spoke to the management team at Viking Therapeutics, Inc. (NASDAQ:VKTX), including CEO Brian Lian, regarding the ...
NYSE:TRC Positive Takeaways of Approval For Development of Multi-family Residential Complex Real estate-development company Tejon Ranch Company (NYSE:TRC) targets maximizing shareholder value through the monetization of its land-based assets. We vie ...
By John Vandermosten, CFANYSE:CVM READ THE FULL CVM RESEARCH REPORT Fiscal Year 2020 Operational and Financial Results On December 30, 2020 CEL-SCI Corporation (NYSE:CVM) reported its fiscal year 2020 operational and financial results for the year en ...